Evidence map›Paper›PMID 32622146›Full record

ArticleJournal of the American Academy of Dermatology2020

Reply to: "Do IL-17 inhibitors increase risk of respiratory tract infections?"

Marilyn T Wan, Daniel B Shin, Kevin L Winthrop, Joel M Gelfand

Abstract readLetterComment
In one paragraph

Article in Journal of the American Academy of Dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Marilyn T WanDepartment of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Daniel B ShinDepartment of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Kevin L WinthropDivision of Infectious Diseases and Public Health, Oregon Health & Sciences University, Portland.
Joel M GelfandDepartment of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia. Electronic address: joel.gelfand@pennmedicine.upenn.edu.

Funding

Study Design and Data AnalysisP30AR069589 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI Elizabeth Anne Grice · 2016 to 2026
$8.6M
NIAMS NIH HHS P30 AR069589
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biological ProductsCOVID-19PsoriasisRespiratory Tract InfectionsDecision MakingHumansInterleukin-17PandemicsSARS-CoV-2Biological ProductsInterleukin-17

Identifiers

PMID32622146
PMCPMC7329655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.